Sep 2026· International Journal of Advanced Research· Vol 14, pp. 1116-1120· 0 citations
TL;DR
Uterine arteriovenous malformation should be considered in patients presenting with abnormal uterine bleeding during follow-up of gestational trophoblastic disease, even after complete β-hCG normalization.
Abstract
Background: Uterine arteriovenous malformation (UAVM) is a rare vascular abnormality that may occur following uterine instrumentation or in association with gestational trophoblastic disease (GTD). Its diagnosis is particularly challenging during post-molar follow-up, as imaging findings may mimic persistent trophoblastic neoplasia. Case Presentation: We report the case of a 42-year-old woman diagnosed with a complete hydatidiform mole with an initial serum β-hCG level of 650,000 IU/L. Following suction evacuation, the patient developed gestational trophoblastic neoplasia and was treated with methotrexate, achieving complete normalization of β-hCG levels at the end of treatment. Four months after uterine evacuation, she presented with metrorrhagia. Pelvic Doppler ultrasonography revealed a uterine arteriovenous malformation. Given the absence of biological evidence of persistent trophoblastic disease and the patient\'s hemodynamic stability, a conservative approach with close clinical and ultrasonographic surveillance was adopted. The patient experienced progressive resolution of vaginal bleeding without the need for invasive intervention. Conclusion: Uterine arteriovenous malformation should be considered in patients presenting with abnormal uterine bleeding during follow-up of gestational trophoblastic disease, even after complete β-hCG normalization. Doppler ultrasonography plays a key role in diagnosis, while conservative management may be a safe and effective option in selected clinically stable patients. Keywords: Gestational trophoblastic neoplasia; Complete hydatidiform mole; Uterine arteriovenous malformation; Doppler ultrasonography; Methotrexate; Conservative management.
Background: Pulmonary epithelioid trophoblastic tumor (ETT) without demonstrable uterine involvement is an exceedingly rare form of gestational trophoblastic neoplasia. Its non-specific presentation often results in misdiagnosis, commonly as ectopic pregnancy. Case Presentation: A 39-year-old woman, para 2, presented w...
Kai Zhang, Juan Zhang, Xing-Kui Xie et al.· Journal of Clinical Medicine· 0 citations
Rationale: Gestational trophoblastic neoplasia, particularly choriocarcinoma, is a rare but aggressive malignancy arising from trophoblastic tissue. Primary tubal choriocarcinoma is exceptionally uncommon and often presents a diagnostic challenge owing to its similarity to ectopic pregnancy. Patient concerns: A 29-year...
Background/Objectives: Gestational choriocarcinoma is an uncommon neoplasia related to pregnancy. Signs and symptoms remain unspecific, while abnormal uterine bleeding is the main symptom. Methods: We report a case of a 40-year-old woman with gestational choriocarcinoma presenting as cervical ectopic pregnancy and a re...
Dimitrios Panagiotopoulos, E. Vafias, Konstantinos Chatzidimitriadis et al.· Precision Oncology· 0 citations
Invasive mole is a rare form of gestational trophoblastic disease characterized by myometrial invasion following a complete or partial molar pregnancy. Spontaneous uterine perforation is an exceptional and potentially life-threatening complication. We report the case of a 55-year-old postmenopausal woman who presented...
Kawtar Iraqi Houssaini, I. Essaoudy, A. Bassir et al.· The Pan African Medical Jour...· 0 citations
Placental site trophoblastic tumor is a rare gestational trophoblastic neoplasm that may present diagnostic and therapeutic challenges, particularly, when arising in the cervix. A 36-year-old multiparous woman presented with amenorrhea and postcoital bleeding. Imaging revealed an 8 × 8.5 × 7.8 cm hypervascular cervical...
Anitha Aldur Manjappa, Jai Chadha, Vijay Guru et al.· The journal of obstetrics an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.